Bayer Removing All Trasylol from U.S. Stock
What the announcement means
According to a press release from the FDA, Bayers announcement means that heart bypass patients can only be given Trasylol if doctors feel that no other alternative is available. In these limited situations, doctors must submit a protocol which will be reviewed by the FDA. While that may mean the end of Trasylol use for most patients, the litigation surrounding the drug is just beginning. In fact, additional lawsuits will likely be filed after critical drug trial information was released today
Canadian study shows 50% Increased Risk of Death
A Canadian study known as BART (Blood Conservation using Antifibrinolytics in a Randomized Trial) that was reviewing the effects of Trasylol in 2007 had to be stopped because too many patients were dying. That news prompted Bayer to pull Trasylol off the market in November 2007 and the medical community, as well as the U.S. Food and Drug Administration (FDA) and Congress, have been waiting for the final results of the study.
results were published today in the highly respected New England Journal of Medicine (NEJM). They showed that Trasylol patients had a 50% increased risk of death over patients who used similar (and far less expensive) drugs to control bleeding. This news prompted Bayer to announce that it removing all remaining Trasylol from U.S. shelves.
Bayer may have known about Trasylol dangers years ago
Analysts say that Trasylol was allegedly given to an estimated one third of all heart bypass patients in the United States from 1993 to 2007. Trasylol attorneys say that it is clear that Bayer knew about the harmful, and perhaps deadly, effects associated with the drug for many years some say that Bayer was aware of the drugs dangers even before it hit the U.S. market but did nothing. As a result, thousands of lives may have been taken too early according to a news segment on CBSs 60 Minutes that aired earlier this year.
If you or a loved one may have been injured or died due to the use of Trasylol, contact an attorney whose practice focuses in this area of law to discuss your situation. The consultation is free and without obligation. To contact a qualified attorney, please click here.